Sunhawk Vision Biotech (ROCO:7759) Shares Outstanding (EOP): 70.07 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7759 Sunhawk Vision Biotech Inc ROCO:7759
12 GF Score
Price NT$31.40
! 1 Warning Sign
View Full Analysis

What is Sunhawk Vision Biotech Shares Outstanding (EOP)?

Sunhawk Vision Biotech ROCO:7759 +0.96% 12 Shares Outstanding (EOP) is 70.07 Mil as of Dec. 2025. GuruFocus rates ROCO:7759 with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Sunhawk Vision Biotech's shares outstanding for the quarter that ended in Dec. 2025 was 70.07 Mil.

Sunhawk Vision Biotech's quarterly shares outstanding stayed the same from Jun. 2025 (70.07 Mil) to Dec. 2025 (70.07 Mil).

Sunhawk Vision Biotech's annual shares outstanding stayed the same from Dec. 2024 (70.07 Mil) to Dec. 2025 (70.07 Mil).


Sunhawk Vision Biotech  (ROCO:7759) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Sunhawk Vision Biotech Shares Outstanding (EOP) Related Terms


Sunhawk Vision Biotech Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Sunhawk Vision Biotech's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunhawk Vision Biotech Shares Outstanding (EOP) Chart

Sunhawk Vision Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial 70.07 70.07 70.07 70.07 70.07

Sunhawk Vision Biotech Semi-Annual Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only 70.07 70.07 70.07 70.07 70.07

ROCO:7759 vs VRTX, REGN, ALNY: Shares Outstanding (EOP) Comparison

For the Biotechnology subindustry, Sunhawk Vision Biotech's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunhawk Vision Biotech Shares Outstanding (EOP) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunhawk Vision Biotech's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Sunhawk Vision Biotech's Shares Outstanding (EOP) falls into.


ROCO:7759
12GF Score
Sunhawk Vision Biotech Inc ROCO:7759
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunhawk Vision Biotech Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 70.07 Mil mean?
Sunhawk Vision Biotech (ROCO:7759) has a Shares Outstanding (EOP) of 70.07 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Sunhawk Vision Biotech and its competitors.
Is Sunhawk Vision Biotech's Shares Outstanding (EOP) too high?
Sunhawk Vision Biotech's current Shares Outstanding (EOP) is 70.07 Mil. Overall, Sunhawk Vision Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Sunhawk Vision Biotech's Shares Outstanding (EOP) compare to VRTX and REGN?
Sunhawk Vision Biotech's Shares Outstanding (EOP) of 70.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Biotechnology company?
A good Shares Outstanding (EOP) depends on the Biotechnology industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Sunhawk Vision Biotech and its competitors. Sunhawk Vision Biotech's current Shares Outstanding (EOP) is 70.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunhawk Vision Biotech stock overvalued right now?
Sunhawk Vision Biotech (ROCO:7759) has a current Shares Outstanding (EOP) of 70.07 Mil. The current Shares Outstanding (EOP) is 70.07 Mil. Sunhawk Vision Biotech's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Sunhawk Vision Biotech (ROCO:7759), the current Shares Outstanding (EOP) is 70.07 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunhawk Vision Biotech Business Description

Address No. 6 Siwei 3rd Road, 17th Floor, Room A1, Lingya District, Kaohsiung, TWN
Sunhawk Vision Biotech Inc is a biotechnology company. The company is focused on developing new solutions for eye health and vision care. The company specializes in research and development of cutting-edge technologies aimed at treating and preventing ocular diseases. Their product portfolio includes products and services for curing dry eyes, myopia, and corneal erosion.
12GF Score

Get the complete analysis for ROCO:7759

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.40
Price